Fifty years
Fifty years
products

PRODUCTS SUPPLIED IN INDIA

Serum - Protection from birth onwards

MR-VAC

Measles & Rubella Vaccine (Live) I.P.

Viral MR-VAC

INDICATION

For active immunization against Measles and Rubella in infants, children, Adolescents and young adults at risk.

ROUTE OF ADMINISTRATION

Subcutaneous injection.

IMMUNIZATION SCHEDULE

MR vaccine is recommended in Infants, children, adolescents and adults. If pregnancy is planned, then an interval of 1 month should be observed after MR vaccination.

SAFETY INFORMATION

MR vaccine is highly safe and well tolerated. Side effects following MR vaccination are mostly mild and transient, and are similar in frequency and severity to those following administration of each of the single antigen products. Side effects following measles vaccination are generally mild and transient. Slight pain and tenderness at the site of injection may occur, sometimes followed by mild fever and local lymphadenopathy. About 7 - 12 days after vaccination, some recipients may experience fever and rash for 1 -2 days.

Side effects following vaccination with rubella vaccine are also mild, particularly in children. Common side effects include pain, redness and induration at the site of injection. Low-grade fever and rash, lymphadenopathy may happen in some recipients. Joint pain may happen among adolescents and adult females but is rare in children and in men.

All side effects are usually transient and resolve completely. Allergic reactions are very rare. The vaccine has been used extensively in many countries in the world for more than 20 years. Billions of doses have been already given to infants, children, adolescents and adults without any safety concern.

COMPOSITION

  • Each single human dose when reconstituted in a volume of 0.5ml contains not less than 1000 CCID50 of live Measles virus particles and 1000 CCID50 of Rubella virus.
PRESENTATION:
Box of 10 single dose vials.
Box of 10 ampoules of 0.5 ml diluent provided separately